You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Maturation Inhibitor

Showing 1 - 25 of 8,037
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GERD in Infants Trial (Omeprazole, AR formula)

Not yet recruiting
  • GERD in Infants
  • (no location specified)
Nov 6, 2023

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

Withdrawn
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 30, 2023

Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

Recruiting
  • Advanced Biliary Tract Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 22, 2023

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Genitourinary Syndrome of Menopause Trial in Leuven (intravaginal laser)

Recruiting
  • Genitourinary Syndrome of Menopause
  • intravaginal laser
  • Leuven, Flemish Brabant, Belgium
    UZ Leuven
Jan 26, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)

Recruiting
  • Renal Allograft Recipients
  • Belatacept
  • +5 more
  • Birmingham, Alabama
  • +14 more
Oct 24, 2022

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)

Recruiting
  • Vascular Access Complication
  • Rawalpindi, Punjab, Pakistan
    Anas Bin Saif
Nov 22, 2021

Pancreatic Ductal Adenocarcinoma Trial in Shanghai (H101, Tislelizumab, lenvatinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2022

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

Recruiting
  • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
  • +2 more
  • Phoenix, Arizona
  • +69 more
Aug 23, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial

Withdrawn
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +28 more
  • Carbon Dioxide Fractional Laser
  • Questionnaire Administration
  • (no location specified)
Jan 5, 2023

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

Active, not recruiting
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • Los Angeles, California
  • +3 more
Feb 22, 2022

Corneal Toxicity in Patients Treated by Belantamab Mafodotin

Completed
  • Myeloma Multiple
  • Collection of datas
  • Dijon, France
  • +9 more
May 31, 2023

NSCLC Metastatic Trial in La Jolla (Nivolumab + Plinabulin)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Nivolumab + Plinabulin
  • La Jolla, California
    UC San Diego Moores Cancer Center
Nov 21, 2022

Melanoma Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)

Recruiting
  • Melanoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Arteriovenous Fistula Maturation in Hemodialysis or Without

Recruiting
  • Chronic Kidney Diseases
  • Data collection in medical records
  • Blood sampling
  • Brussels, Belgium
    Brugmann University Hospital
Oct 27, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)

Active, not recruiting
  • Congenital Adrenal Hyperplasia (CAH)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023

Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 13, 2023

Infertility, Female, Oocyte Maturation Trial in Valencia (Controlled ovarian stimuation, Oocyte pick up, Oocyte in vitro

Recruiting
  • Infertility, Female
  • Oocyte Maturation
  • Controlled ovarian stimuation
  • +3 more
  • Valencia, Spain
    Ivi Valencia
Oct 23, 2023

Arteriovenous Fistula Occlusion Trial in Taipei (No intervention)

Completed
  • Arteriovenous Fistula Occlusion
  • No intervention
  • Taipei, No.7, Chung Shan S. Rd, Taiwan
    National Taiwan University Hospital
Apr 16, 2023

Gastric Cancer Metastatic to Liver Trial in Shanghai (Cryoablation, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Gastric Cancer Metastatic to Liver
  • Cryoablation
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 6, 2023